Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

  • Showing results for arutyunov gp. Your search for Arutynov GP retrieved no results.
1.

[Quality of life in patients with heart failure with preserved ejection fraction and the bendopnea symptom].

Dragunov DO, Sokolova AV, Arutyunov GP, Gasanova AD, Latyshev TV.

Kardiologiia. 2019 Jul 24;59(6S):24-32. doi: 10.18087/cardio.2507. Russian.

PMID:
31340746
2.

Morphofunctional Features of The Diaphragm in Patients With Chronic Heart Failure.

Arutyunov AG, Ilyina KV, Arutyunov GP, Kolesnikova EA, Pchelin VV, Kulagina NP, Tokmin DS, Tulyakova EV.

Kardiologiia. 2019 Jan 27;59(1):12-21. doi: 10.18087/cardio.2019.1.2625. Russian.

PMID:
30710984
3.

Features of diagnostics and treatment of chronic heart failure in elderly and senile patients. Expert opinion of the Society of Experts in Heart Failure, Russian Association of Gerontologists, and Euroasian Association of Therapists.

Orlova IA, Tkacheva ON, Arutyunov GP, Kotovskaya YV, Lopatin YM, Mareev VY, Mareev YV, Runihina NK, Skvortsov AA, Strazhesko ID, Frolova EV.

Kardiologiia. 2018 Dec 26;58(12S):42-72. doi: 10.18087/cardio.2560. Russian.

PMID:
30625107
4.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.

N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.

PMID:
30415628
5.

[Significance of adipose tissue mass for the clinical course of pneumonia associated with decompensated CHF].

Simbirtseva AS, Arutyunov GP, Bylova NA, Arutyunov AG, Simbirtsev SY.

Kardiologiia. 2018 SOct;(S10):61-68. Russian.

PMID:
30362430
6.

[Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment].

Mareev VY, Fomin IV, Ageev FT, Begrambekova YL, Vasyuk YA, Garganeeva AA, Gendlin GE, Glezer MG, Gote SV, Dovzhenko TV, Kobalava ZD, Koziolova NA, Koroteev AV, Mareev YV, Ovchinnikov AG, Perepech NB, Tarlovskaya EI, CHesnikova AI, Shevchenko AO, Arutyunov GP, Belenkov YN, Galyavich AS, Gilyarevskiy SR, Drapkina OM, Duplyakov DV, Lopatin YM, Sitnikova MY, Skibitskiy VV, SHlyakhto EV.

Kardiologiia. 2018 SJun;58 Suppl 6:1-164. Russian. No abstract available.

PMID:
30081796
7.

[Factors associated with levels of interleukins -18, -8, and -6 in hypertensive patients at high and very high cardiovascular risk].

Arutyunov GP, Dragunov DO, Sokolova AV, Mitrokhin VM, Kamkin AG, Latyshev TV.

Kardiologiia. 2017 Mar;57(S3):69-75. Russian.

PMID:
29466192
8.

[Correlations of IL-18 and IL-6 with sodium consumption in patients with arterial hypertension and diabetes mellitus].

Arutyunov GP, Dragunov DO, Sokolova AV, Mitrokhin VM, Kamkin AG, Latyshev TV.

Kardiologiia. 2017 SJan;57(S1):355-359. Russian.

PMID:
29276908
9.

[Prognostic role of body composition in patients with pneumonia associated with decompensated CHF].

Bylova NA, Arutyunov GP, Rylova AK, Simbirtseva AS, Arutyunov AG.

Kardiologiia. 2017 SFeb;57(S2):343-350. Russian.

PMID:
29276901
10.

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.

Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, Lüscher TF, Arutyunov GP, Motro M, Mori C, Roubert B, Pocock SJ, Ponikowski P.

Eur J Heart Fail. 2018 Jan;20(1):125-133. doi: 10.1002/ejhf.823. Epub 2017 Apr 24. Review.

11.

[Comparative Analysis of the Efficacy and Safety of Rosuvastatin and Original Rosuvastatin].

Bart BY, Luchinkina EE, Gordeev IG, Arutyunov GP, Taratukhin On Behalf Of The Workgroup Of Paritet Trial EO.

Kardiologiia. 2016 Jun;56(6):46-49. Russian.

PMID:
28290847
12.

[The effect of the level of total sodium deposited in the myocardium on its stiffness].

Arutyunov GP, Dragunov DO, Arutyunov GP, Sokolova AV, Papyshev IP, Kildyushov EM, Negrebetsky VV, Fedorova VN.

Ter Arkh. 2017;89(1):32-37. doi: 10.17116/terarkh201789132-37. Russian.

PMID:
28252624
13.

[Impact of the dosing of basic drugs on the risk of rehospitalization in patients with chronic heart failure].

Arutyunov AG, Dragunov DO, Arutyunov GP, Sokolova AV.

Ter Arkh. 2016;88(1):29-34. doi: 10.17116/terarkh201688129-34. Russian.

PMID:
26978606
14.

A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.

Brigandi RA, Johnson B, Oei C, Westerman M, Olbina G, de Zoysa J, Roger SD, Sahay M, Cross N, McMahon L, Guptha V, Smolyarchuk EA, Singh N, Russ SF, Kumar S; PHI112844 Investigators.

Am J Kidney Dis. 2016 Jun;67(6):861-71. doi: 10.1053/j.ajkd.2015.11.021. Epub 2016 Jan 27.

15.

[First Open Study of Syndrome of Acute Decompensation of Heart Failure and Concomitant diseases in Russian Federation: Independent Registry ORAKUL].

Arutyunov AG, Dragunov DO, Arutyunov GP, Rylova AK, Pashkevich DD, Viter KV; ORAKUL.

Kardiologiia. 2015;55(5):12-21. Russian.

PMID:
26615619
16.

2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).

Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W; ESC Scientific Document Group .

Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318. Epub 2015 Aug 29. No abstract available.

17.

[First Open Study of Syndrome of Acute Decompensation of Heart Failure and Concomitant Diseases in Russian Federation: Independent Registry ORAKUL].

Arutyunov AG, Dragunov DO, Arutyunov GP, Rylova AK, Pashkevich DD, Viter On Behalf Of The Study Group KV.

Kardiologiia. 2015 May;55(5):12-21. Russian.

PMID:
28294906
18.

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.

Brinton EA, Kher U, Shah S, Cannon CP, Davidson M, Gotto AM, Ashraf TB, McCrary Sisk C, Dansky H, Mitchel Y, Barter P; DEFINE Investigators.

J Clin Lipidol. 2015 Jan-Feb;9(1):65-71. doi: 10.1016/j.jacl.2014.10.005. Epub 2014 Nov 4.

PMID:
25670362
19.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

20.

Safety of anacetrapib in patients with or at high risk for coronary heart disease.

Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM, Stepanavage M, Liu SX, Gibbons P, Ashraf TB, Zafarino J, Mitchel Y, Barter P; Determining the Efficacy and Tolerability Investigators.

N Engl J Med. 2010 Dec 16;363(25):2406-15. doi: 10.1056/NEJMoa1009744. Epub 2010 Nov 17.

Supplemental Content

Loading ...
Support Center